Status:
COMPLETED
Behavioural Science Messages in Breast Cancer Screening
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
NHS England
Conditions:
Breast Cancer
Eligibility:
FEMALE
50-70 years
Phase:
NA
Brief Summary
Breast cancer is the most common cancer in the United Kingdom, with 1 in 8 women affected during their lifetime. Whilst survival rates are high, the 5-year survival rate is 72% higher with the earlies...
Detailed Description
This study will be conducted as a randomised control trial in the London screening region of the National Health Service Breast Screening Programme. The study will last over 6 months. The administrati...
Eligibility Criteria
Inclusion
- The inclusion criteria will match those used by the National Health Service Breast Screening Programme, as all invitations will come directly from the programme, as per usual care. These include:
- Aged between 50 to 70 at the time of invitation
- Lives within London screening region
- Registered as female with primary care physician
- The exclusion criteria will match those used by the National Health Service Breast Screening Programme, as all invitations will come directly from the programme, as per usual care. These include:
- Previous attendance at breast screening in the current (3-year cycle)
- Opted out of receiving text messages
- Opted out of screening
- Previous bilateral mastectomy
Exclusion
Key Trial Info
Start Date :
July 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2023
Estimated Enrollment :
34047 Patients enrolled
Trial Details
Trial ID
NCT05395871
Start Date
July 15 2022
End Date
January 15 2023
Last Update
January 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NHS Breast Screening Hub
Edgware, London, United Kingdom